Literature DB >> 4126765

Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes.

S Rudikoff, E B Mushinski, M Potter, C P Glaudemans, M E Jolley.   

Abstract

Six IgA myeloma proteins of BALB/c origin which bind antigens containing beta-(1 --> 6)-D-galactan side chains have been isolated by affinity chromatography on galactoside-BSA-Sepharose columns. Partial amino acid sequences of of the light chains to residue Cys23 and the heavy chains to reside 30 were determined on the automated sequencer. No differences were found among the six V(K) sequences. Among some 50 partial V(K) sequences that have thus far been determined these six chains are the only ones thus far identified in this subgroup; at least 25 V(K) subgroups in the mouse have been identified so far. The heavy chain partial sequences were also very closely related but two differences were found. One protein differed from the other five by having isoleucine instead of leucine at position 5, a second protein differed from the others by having an unidentified amino acid at position 19. Using the highly sensitive inhibition of hemagglutination method it was found that each of the proteins possessed a unique inidividual antigenic determinant.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126765      PMCID: PMC2139432          DOI: 10.1084/jem.138.5.1095

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

2.  Mouse immunoglobulin chains. Partial amino acid sequence of a kappa chain.

Authors:  D McKean; M Potter; L Hood
Journal:  Biochemistry       Date:  1973-02       Impact factor: 3.162

3.  Antigen-binding IgA myeloma proteins in mice: specificities to antigens containing -D 1 leads to 6 linked galactose side chains and a protein antigen in wheat.

Authors:  M Potter; E B Mushinski; C P Glaudemans
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

4.  Reconstitution from subunits of the hapten binding sites and idiotypic determinants of mouse anti-phosphorylcholine myeloma proteins.

Authors:  A Sher; E Lord; M Cohn
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

5.  Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment.

Authors:  M Potter; J G Pumphrey; J L Walters
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

6.  Variability in the lambda light chain sequences of mouse antibody.

Authors:  M G Weigert; I M Cesari; S J Yonkovich; M Cohn
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

7.  On the location and structure of the active sites of antibody molecules.

Authors:  S J Singer; N O Thorpe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

8.  Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide.

Authors:  E J Goetzl; H Metzger
Journal:  Biochemistry       Date:  1970-09-29       Impact factor: 3.162

9.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline.

Authors:  M Potter; R Lieberman
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  12 in total

1.  History of Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Authors:  Kenneth L Kirk; Kenneth A Jacobson
Journal:  Bull Hist Chem       Date:  2014-01-01

2.  Subunit interactions in mouse myeloma proteins with anti-galactan activity.

Authors:  B N Manjula; C P Glaudemans; E B Mushinski; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

3.  Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.

Authors:  S Rudikoff; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  kappa Chain joining segments and structural diversity of antibody combining sites.

Authors:  S Rudikoff; D N Rao; C P Glaudemans; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions.

Authors:  D N Rao; S Rudikoff; H Krutzsch; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Human and murine phosphorycholine-binding immunoglobulins: conserved subgroup and first hypervariable region of heavy chains.

Authors:  W F Riesen; D G Braun; J C Jaton
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

7.  The murine immunoglobulin alpha gene expresses multiple transcripts from a unique membrane exon.

Authors:  C J Word; J F Mushinski; P W Tucker
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

8.  Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice.

Authors:  R Lieberman; M Potter; W Humphrey; E B Mushinski; M Vrana
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

9.  Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies.

Authors:  J L Claflin; J M Davie
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins.

Authors:  J L Claflin; J M Davie
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.